Ameriprise’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.9M Sell
255,585
-5,677
-2% -$131K ﹤0.01% 2231
2025
Q1
$7.05M Buy
261,262
+246,356
+1,653% +$6.65M ﹤0.01% 2037
2024
Q4
$798K Buy
14,906
+9,636
+183% +$516K ﹤0.01% 3309
2024
Q3
$239K Buy
+5,270
New +$239K ﹤0.01% 3695